0000899243-18-007927.txt : 20180319
0000899243-18-007927.hdr.sgml : 20180319
20180319160603
ACCESSION NUMBER: 0000899243-18-007927
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180315
FILED AS OF DATE: 20180319
DATE AS OF CHANGE: 20180319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sprague John M
CENTRAL INDEX KEY: 0001730056
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 18698777
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-15
0
0001492674
T2 Biosystems, Inc.
TTOO
0001730056
Sprague John M
101 HARTWELL AVENUE
LEXINGTON
MA
02421
0
1
0
0
CFO
Performance Restricted Stock Units
2018-03-15
4
A
0
69170
0.00
A
2021-03-15
Common Stock
69170
69170
D
Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon the achievement of certain pre-established 90-day average daily closing prices per share goals over a three-year performance period
/s/ Michael Gibbs, Attorney-in-Fact
2018-03-19